Chambers Review
Covington & Burling is the preferred choice for many when it comes to life sciences matters, drawing from a pool of regulatory and industry experts to advise on growth investment transactions. The group's wider sector expertise also covers technology and cleantech. It regularly works with investors and emerging companies on venture financings as well as advising on post-investment management operations. Covington & Burling is well positioned to handle cross-border investments involving US and European entities.
Work Highlights
- Covington & Burling advised Oxford Science Enterprises on its £112.5 million Series B investment round in PepGen.
Strengths
Provided by Chambers
"They are technically very competent and experienced, and also assisted us in resolving commercial issues."
"They are extremely experienced in the space, find sensible solutions to issues and will stand firm when needed. It's excellent service."
"Covington & Burling is very experienced in the VC space, and is good at finding practical solutions to navigate issues."
"They are technically very competent and experienced, and also assisted us in resolving commercial issues."
"They are extremely experienced in the space, find sensible solutions to issues and will stand firm when needed. It's excellent service."
"Covington & Burling is very experienced in the VC space, and is good at finding practical solutions to navigate issues."
Notable Practitioners
James Gubbins maintains an excellent venture capital practice as part of a broader offering that incorporates expertise in M&A and IPOs. His work focuses on deals in the life sciences and technology sectors.
"James Gubbins has significant experience and knowledge of the life science sector."